Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Non-cash Items (2016 - 2018)

IGC Pharma (IGC) has disclosed Non-cash Items for 4 consecutive years, with $105884.0 as the latest value for Q1 2018.

  • On a quarterly basis, Non-cash Items changed N/A to $105884.0 in Q1 2018 year-over-year; TTM through Mar 2018 was $105884.0, a N/A change, with the full-year FY2018 number at $105884.0, changed N/A from a year prior.
  • Non-cash Items was $105884.0 for Q1 2018 at IGC Pharma, down from $130045.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $130045.0 in Q2 2015 to a low of $105884.0 in Q1 2018.
  • A 3-year average of $125212.8 and a median of $130045.0 in 2015 define the central range for Non-cash Items.
  • Biggest YoY gain for Non-cash Items was 0.0% in 2016; the steepest drop was 0.0% in 2016.
  • IGC Pharma's Non-cash Items stood at $130045.0 in 2015, then changed by 0.0% to $130045.0 in 2016, then fell by 18.58% to $105884.0 in 2018.
  • Per Business Quant, the three most recent readings for IGC's Non-cash Items are $105884.0 (Q1 2018), $130045.0 (Q3 2016), and $130045.0 (Q4 2015).